2011 Molecular Pharmacology GRC and GRS

2011年分子药理学GRC和GRS

• 批准号: 8059911
• 负责人: PAUL A INSEL
• 金额: $ 2.5万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-01-07 至 2011-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8059911
• 关键词: Animal Model; Area; Basic Science; Behavior; Biology; Cardiovascular Diseases; Cells; Cellular biology; Chemistry; Clinical; Clinical Medicine; Development; Diagnostic; Discipline; Disease; Drug Addiction; Drug Receptors; Drug effect disorder; Drug usage; Endocrine System Diseases; Genomics; Infection; Malignant Neoplasms; Medicine; Molecular; Molecular Biology; Pharmacology; Physiology; Postdoctoral Fellow; Regulation; Research; Research Personnel; Role; Scientist; Senior Scientist; Signal Transduction; Students; System; Systems Biology; Therapeutic Agents; Training; Translational Research; Underrepresented Minority; United States National Institutes of Health; Update; Vision; Woman; base; body system; experience; graduate student; meetings; next generation; planetary Atmosphere; programs; structural biology; symposium; tool

DESCRIPTION (provided by applicant): Molecular Pharmacology focuses on the mechanisms of drug action at a molecular level. The use of drugs as clinical diagnostic and therapeutic agents and in studying mechanisms in physiology and disease makes molecular pharmacology a very dynamic discipline in experimental biology and medicine. Molecular pharmacology is an interface discipline that integrates approaches from fields that include molecular, cellular and structural biology, genomics, chemistry and systems biology. Research in molecular pharmacology seeks to elucidate fundamental aspects of drug action and provide new pharmacological tools and therapies. In addition, progress in clinical medicine has raised new questions regarding the molecular basis of drug action. The placement of molecular pharmacology at the interface of experimental biology and translational research makes it an exciting area of discovery that seeks to provide answers to questions of relevance to clinical medicine. These ideas underlie this application for NIH support for the 2011 Molecular Pharmacology Gordon Research Conference (GRC), which seeks to integrate basic and translational research and to highlight recent advances regarding molecular mechanisms and pathophysiological aspects of drug receptors in cell systems and animal models. Topics at this GRC will be in areas that include signaling and drug action in cancer, infection, cardiovascular and endocrine disorders as well as evolving information regarding critical molecular aspects that contribute to behavior, drugs of addiction and the regulation of multiple organ systems. PUBLIC HEALTH RELEVANCE: Beyond its role in updating information within the field, the Molecular Pharmacology GRC contributes to the training and creative development of the next generation of scientists who will drive the field forward. The intimate, informal atmosphere of the conference gives trainees (e.g., graduate students and post-doctoral fellows) an opportunity to experience the excitement of cutting-edge research and to interact with senior scientists.

描述（由申请人提供）：分子药理学专注于分子水平的药物作用机制。使用药物作为临床诊断和治疗剂，以及研究生理学和疾病的机制，使分子药理学成为实验生物学和医学中非常动态的学科。分子药理学是一门界面学科，它整合了包括分子，细胞和结构生物学，基因组学，化学和系统生物学的领域的方法。分子药理学研究旨在阐明药物作用的基本方面，并提供新的药理学工具和疗法。此外，临床医学的进展提出了有关药物作用的分子基础的新问题。分子药理学在实验生物学和转化研究界面上的放置使其成为一个令人兴奋的发现领域，旨在为与临床医学相关的问题提供答案。这些思想是对2011年分子药理学戈登研究会议（GRC）的NIH支持的基础，该会议旨在整合基础和转化研究，并强调细胞系统和动物模型中药物受体的分子机制和病理生理方面的最新进展。该GRC的主题将在包括癌症，感染，心血管和内分泌疾病中的信号传导和药物作用的领域，以及有关有助于行为，成瘾药物和多个器官系统调节的关键分子方面的信息。 公共卫生相关性：除了在更新该领域的信息方面的作用外，分子药理学GRC为下一代科学家的培训和创造性发展做出了贡献，他们将推动该领域的前进。会议的亲密而非正式的氛围使学员（例如，研究生和博士后研究员）有机会体验尖端研究的兴奋并与高级科学家互动。